Clinical Trials Directory

Trials / Completed

CompletedNCT01423019

A Comparative Effectiveness Study Evaluating the Effects of Thermogenic Supplements on Body Composition

A Comparative Effectiveness Study Evaluating the Effects of Two Thermogenic Supplements on Body Composition Using a Double-Blinded Placebo-Controlled Protocol

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Integrative Health Technologies, Inc. · Network
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether subjects taking a supplement designed to increase metabolic rate will have a positive effect on body composition (fat mass, muscle mass, and bone density.)

Detailed description

In a previous randomized double-blinded placebo-controlled pilot study, subjects taking the nutritional supplements contained in these two weight loss plans had a short-term statistically significant increase in their resting metabolic rates as compared to taking a placebo. No increases were found in blood pressure, resting heart rate, or self-reported discomfort when taking the supplement. The current study was designed to extend the findings of the pilot study over a 60-day study period using a randomized double-blinded placebo-controlled protocol with the same weight loss interventions.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAdvantra ZTwo capsules are taken twice daily, 20-30 minutes before breakfast and evening meals. Two capsules contain a total of 50 mg p-synephrine.
DIETARY_SUPPLEMENTAdvantra Z + Naringin + HesperidenTwo capsules are taken twice daily, 20-30 minutes before breakfast and evening meals. Two capsules contain a total of 50 mg p-synephrine, 600 mg naringin, and 100 mg hesperiden.
OTHERSugar pillTwo capsules containing inert ingredients are taken twice daily, 20-30 minutes before breakfast and evening meals.

Timeline

Start date
2011-10-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2011-08-25
Last updated
2012-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01423019. Inclusion in this directory is not an endorsement.